Status:
COMPLETED
Calhoun Vision Light Adjustable Lens (LAL) in Subjects With Pre-Existing Corneal Astigmatism
Lead Sponsor:
Calhoun Vision, Inc.
Conditions:
Cataract
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
The purpose is to evaluate the Calhoun Vision Light Adjustable Lens (LAL) and Light Delivery Device (LDD) for reducing astigmatism and improving uncorrected vision after implantation.
Eligibility Criteria
Inclusion
- Undergoing cataract surgery and be willing to have LAL or commercially available IOL implanted
- Pre-operative regular corneal astigmatism of \>= 0.75 diopters and \<= 2.0 diopters
- Best spectacle corrected visual acuity reduced to 20/40 or worse with or without glare
- Projected best spectacle corrected visual acuity of 20/20 or better
- Clear intraocular media other than cataract
- Potentially good vision in fellow eye
- Fully dilated pupil of \>= 7.0 mm
Exclusion
- Zonular laxity or dehiscence
- Pseudoexfoliation
- Age related macular degeneration
- Retinal degenerative disorder
- Diabetes with any evidence of retinopathy
- Glaucomatous optic neuropathy, uveitis, significant anterior segment pathology, keratoconus
- Corneal dystrophy, previous corneal or intraocular surgery
- Complications during cataract surgery
- Serious co-morbid conditions
- Systemic medications that my increase UV sensitivity
- Irregular astigmatism
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT01496066
Start Date
December 1 2011
End Date
June 1 2016
Last Update
June 29 2018
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Vold Vision
Fayetteville, Arkansas, United States, 72704
2
Jules Stein Eye Institute
Los Angeles, California, United States, 90095
3
Wolstan & Goldberg Eye Associates
Torrance, California, United States, 90505
4
Newsom Eye
Sebring, Florida, United States, 33870